Package 63868-821-25

Brand: olopatadine hydrochloride ophthalmic solution

Generic: olopatadine hydrochloride ophthalmic
NDC Package

Package Facts

Identity

Package NDC 63868-821-25
Digits Only 6386882125
Product NDC 63868-821
Product ID 63868-821_e9018310-14d0-1f1e-7bc1-c5ba9d88696b
Description

1 BOTTLE, PLASTIC in 1 CARTON (63868-821-25) / 2.5 mL in 1 BOTTLE, PLASTIC

Marketing

Marketing Status
Marketed Since 2021-01-01
Brand olopatadine hydrochloride ophthalmic solution
Generic olopatadine hydrochloride ophthalmic
Sample Package No

Linked Drug Pages (1)

Olopatadine Hydrochloride Ophthalmic Solution ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "e9018310-14d0-1f1e-7bc1-c5ba9d88696b", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111343"], "spl_set_id": ["f6d70b01-941b-b796-ceee-7f24b6038e7d"], "manufacturer_name": ["Chain Drug Marketing Association INC"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (63868-821-25)  / 2.5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "63868-821-25", "marketing_start_date": "20210101"}], "brand_name": "Olopatadine Hydrochloride Ophthalmic Solution", "product_id": "63868-821_e9018310-14d0-1f1e-7bc1-c5ba9d88696b", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "63868-821", "generic_name": "Olopatadine Hydrochloride Ophthalmic", "labeler_name": "Chain Drug Marketing Association INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Olopatadine Hydrochloride Ophthalmic Solution", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA209752", "marketing_category": "ANDA", "marketing_start_date": "20210101", "listing_expiration_date": "20261231"}